Revisiting the role of TEG-PM in stroke prevention by drug selection for mono-antiplatelet medication following dual-antiplatelet treatment

CONCLUSION: The TEG-PM could be a tangible preprocessing in drug selection for MAPT following DAPT in patients with minor strokes or TIAs, especially for those with non-stented ICASs.PMID:38295427

Source: Neuroendocrinology Letters - January 31, 2024 Category: Endocrinology Authors: Lei Yan Wenzhao Liang Bingyang Zhao Zhongyu Zhao Kai Zhang Lingling Wang Jing Mang Source Type: research